Patents by Inventor CHEN-CHEN LEE

CHEN-CHEN LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Suppression of allergic lung inflammation and hyperreactivity
    Patent number: 11007248
    Abstract: This disclosure relates to compositions of isolated polypeptides and methods of their use for the treatment and prevention of disease or disease symptoms associated with MARCKS phosphorylation and/or dissociation from the cell membrane, including but not limited to allergic inflammation, asthma, chronic bronchitis, COPD, infection, hyper-reactivity, cystic fibrosis, ulcerative colitis, Crohn's disease, irritable bowel syndrome, rosacea, eczema, psoriasis, acne, arthritis, rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: May 18, 2021
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Reen Wu, Ching-Hsien Chen, Chen-Chen Lee
  • SUPPRESSION OF ALLERGIC LUNG INFLAMMATION AND HYPERREACTIVITY
    Publication number: 20200206308
    Abstract: This disclosure relates to compositions of isolated polypeptides and methods of their use for the treatment and prevention of disease or disease symptoms associated with MARCKS phosphorylation and/or dissociation from the cell membrane, including but not limited to allergic inflammation, asthma, chronic bronchitis, COPD, infection, hyper-reactivity, cystic fibrosis, ulcerative colitis, Crohn's disease, irritable bowel syndrome, rosacea, eczema, psoriasis, acne, arthritis, rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus.
    Type: Application
    Filed: April 25, 2019
    Publication date: July 2, 2020
    Inventors: Reen Wu, Ching-Hsien Chen, Chen-Chen Lee
  • Suppression of allergic lung inflammation and hyperreactivity
    Patent number: 10314889
    Abstract: This disclosure relates to compositions of isolated polypeptides and methods of their use for the treatment and prevention of disease or disease symptoms associated with MARCKS phosphorylation and/or dissociation from the cell membrane, including but not limited to allergic inflammation, asthma, chronic bronchitis, COPD, infection, hyper-reactivity, cystic fibrosis, ulcerative colitis, Crohn's disease, irritable bowel syndrome, rosacea, eczema, psoriasis, acne, arthritis, rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: June 11, 2019
    Assignee: The Regents of the University of California
    Inventors: Reen Wu, Ching-Hsien Chen, Chen-Chen Lee
  • SUPPRESSION OF ALLERGIC LUNG INFLAMMATION AND HYPERREACTIVITY
    Publication number: 20170028019
    Abstract: This disclosure compositions and methods for the treatment and prevention of allergic inflammation and diseases associated with such, e.g., asthma.
    Type: Application
    Filed: December 19, 2014
    Publication date: February 2, 2017
    Applicant: The Regents of the University of California
    Inventors: Reen Wu, Ching-Hsien Chen, Chen-Chen Lee
  • Method for inhibiting production of cytokines of T helper cell type II and/or inhibiting production of chemokines using brazilin
    Patent number: 8796327
    Abstract: A method for inhibiting the production of cytokines of T helper cell type II (Th2 cell) and/or inhibiting the production of chemokines in a mammal is provided, wherein the method comprises administrating to the mammal an effective amount of an active component selected from a group consisting of a compound of formula (I), pharmaceutically acceptable salts and esters of the compound, and combinations thereof:
    Type: Grant
    Filed: August 5, 2010
    Date of Patent: August 5, 2014
    Assignee: China Medical University
    Inventors: Chen-Chen Lee, Chien-Neng Wang
  • METHOD FOR INHIBITING PRODUCTION OF CYTOKINES OF T HELPER CELL TYPE II AND/OR INHIBITING PRODUCTION OF CHEMOKINES USING BRAZILIN
    Publication number: 20110213023
    Abstract: A method for inhibiting the production of cytokines of T helper cell type II (Th2 cell) and/or inhibiting the production of chemokines in a mammal is provided, wherein the method comprises administrating to the mammal an effective amount of an active component selected from a group consisting of a compound of formula (I), pharmaceutically acceptable salts and esters of the compound, and combinations thereof:
    Type: Application
    Filed: August 5, 2010
    Publication date: September 1, 2011
    Inventors: CHEN-CHEN LEE, Chien-Neng Wang